Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

The Supplementary Protection Certificate (SPC) manufacturing waiver becomes operational!

1 July 2022

Open

The off-patent medicines industry is a vital part of the solution for healthcare resilience

30 June 2022

Open

Smart reform of EU pharma and IP legislation key to boosting access to essential medicines

28 June 2022

Open

EPSCO (Health) Council – Open letter from Medicines for Europe Executive Committee to European Health Ministers and responsible European Commissioners on inflation impacting the supply of essential medicines

9 June 2022

Open

EU can do more for patients with smart use of biosimilar medicines

28 April 2022

Open

Central & Eastern European patients have inequitable access to medicines for life-threatening conditions

25 April 2022

Open

Correo Farmaceutico – Elisabeth Stampa Stampa, Presidenta de Medicines for Europe y Consejera Delegata de Medichem

31 March 2022

Open

EU pharmaceutical legislation must support a competitive off-patent industry to deliver equitable access to medicines

20 December 2021

Open

Strong support for new measures to protect patient access to medicines in Northern Ireland

20 December 2021

Open

Biosimilar medicines have delivered 18BN€ total savings for Europe but more action needed to translate this potential into patient access and sustainable health

15 December 2021

Open

Subscribe to our newsletter